Patent details
EP3202418 Title: CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE
Basic Information
- Publication number:
- EP3202418
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP161832126
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE
- French Title of Invention:
- ANTICORPS MONOCLONAL ANTI-LAG-3 CYTOTOXIQUE ET SON UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION D'UN REJET DU GREFFON D'ORGANE ET DE MALADIES AUTO-IMMUNES
- German Title of Invention:
- ZYTOTOXISCHER MONOKLONALER ANTI-LAG-3-ANTIKÖRPER UND SEINE VERWENDUNG BEI DER BEHANDLUNG UND VORBEUGUNG VON ORGANTRANSPLANTATABSTOSSUNG UND AUTOIMMUNERKRANKUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 15/09/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 25/09/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 23/08/2023
- Unitary Effect Registration Date:
- 25/09/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 30/04/2008
- Grant date:
- 23/08/2023
- EP Publication Date:
- 09/08/2017
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/08/2023
- EP B1 Publication Date:
- 23/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 30/04/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/08/2023
- Name:
- INSERM (Institut National de la Santé et de la Recherche Scientifique)
- Address:
- 101 rue de Tolbiac, 75654 Paris Cedex 13, France (FR)
- Name:
- Immutep
- Address:
- Parc Club Orsay 2 rue Jean Rostand, 91893 Orsay Cedex, France (FR)
Inventor
1
- Name:
- HAUDEBOURG, Thomas
- Address:
- France (FR)
2
- Name:
- TRIEBEL, Frédéric
- Address:
- France (FR)
3
- Name:
- VANHOVE, Bernard
- Address:
- France (FR)
Priority
- Priority Number:
- 07290545
- Priority Date:
- 30/04/2007
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 39/00; C07K 16/28; C12N 5/0783;
Publication
European Patent Bulletin
1
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202343
- Publication date:
- 25/10/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202343
- Publication date:
- 25/10/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|